Drug Database
Back to search

France· FR:63066469

DIFFERINE 0,1 %, gel

A adapalene product containing adapalène, registered in France by GALDERMA INTERNATIONAL, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC D10AD03

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedDIFFERINE 0,1 %, gelATCD10AD03REGISTER NO.FR:63066469PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about adapalèneAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Adapalene is registered in 16 of 19 countries.

Countries holding a registration under ATC D10AD03 (adapalene), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 9 of them publish a price we can compare per daily dose
Search adapalene products by name

Adapalene · ATC D10AD03

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
ADAPALÈNE
Manufacturer
GALDERMA INTERNATIONAL
Country
France (FR)
ATC code
D10AD03
ATC class
Adapalene
Defined daily dose
1 mg, T
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400933788742
    1 tube(s) polyéthylène de 30 g
    EUR 3.8

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

80 interactions on record for adapalene.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check adapalene against other medicinesHow interaction checks work

Adapalene · interactions on record

80 records

  • 1 severe
  • 8 moderate
  • 71 info

Most severe, free to view

  • Aminolevulinic acidL01XD04severe
  • Salicylic acidD01AE12moderate
  • IsotretinoinD10AD04moderate
  • Benzoyl peroxideD10AE01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Adapalene in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All adapalene products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Differin
  • Belgium · Differin
  • Cyprus · Adaferin
  • Czechia · Belakne, Differine
  • Germany · Differin, Dipalen
  • Denmark · Redap
  • Estonia · Differin
  • Spain · Differine
  • Finland · Differin
  • United Kingdom (Northern Ireland) · Differin
  • Greece · Adaferin
  • Croatia · Sona
  • Hungary · Differin
  • Ireland · Differin
  • Iceland · Differin
  • Italy · Differin
  • Lithuania · Differin
  • Luxembourg · Differin
  • Latvia · Differin
  • Malta · Differin
  • Netherlands · Differin
  • Norway · Differin
  • Poland · Acnelec, Differin
  • Portugal · Differin
  • Sweden · Differin
  • Slovenia · Belakne
  • Slovakia · Belakne, Differine

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f60a2b64-b732-41f4-b071-3951806ed1ca
GET /v1/drugs/f60a2b64-b732-41f4-b071-3951806ed1ca?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "63066469",
  "date_amm": "1994-09-26",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "ADAPALÈNE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "gel",
  "voies_administration": "cutanée",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about adapalene.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console